to evaluate the effectiveness of chlorhexidine chip as an adjunct to scaling and root planing in patient with type 2 diabetes mellitus
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/02/017389
- Lead Sponsor
- Dr Belim Wasim Siraj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Subjects with chronic periodontitis and with minimum 1 site with probing pocket depth of 5-7mm (moderate to deep pocket)
2)Subjects with Controlled type 2 diabetes mellitus (Diabetic control will be measured by glycosylated haemoglobin (HbA1c) in blood samples) in well controlled diabetic patients, HbA1c levels should be <7.0%
3)Subjects with minimum of 14 teeth present
4)Subject who has given written consent.
Exclusion Criteria
1)Presence of overhanging restoration,
2)Smoking,
3)Pregnant women, & Lactating mother
4)Those who have received antibiotics or any form of periodontal treatment in the previous 3months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to evaluate the effectiveness of chlorhexidine chip as an adjunct to scaling and root planing in type 2 diabetes mellitus patientsTimepoint: the outcome will be meassured at base line than <br/ ><br>after 1 week than <br/ ><br>after 1 month and <br/ ><br>after 3 months
- Secondary Outcome Measures
Name Time Method To compare the efficacy of controlled released chlorhexidine chip (PerioColTM-CG) as an adjunct to scaling and root planing and scaling and root planing alone in the treatment of chronic periodontitis in type 2 diabetes mellitus.Timepoint: the treatment outcome will be meassured <br/ ><br>at the baseline <br/ ><br>after 1 week than <br/ ><br>after 1 month and than <br/ ><br>after3 months